Philip Ashman
Senior Vice President
the market access strategy
Alimera Sciences
Portugal
Biography
Dr. Philip Ashman has been Senior Vice President and European Director since January 1, 2013. Prior to joining us, Dr. Ashman held a number of leadership roles at Bayer from 2006 to 2012, and more recently was responsible for leading the market access strategy in the UK to Bayer, covering all therapeutic areas, including ophthalmology. Prior to that, Dr. Ashman was Bayer's Vice President of Global Marketing in Oncology and also Regional Vice President, Oncology Business Unit (Europe), and was responsible for oncology sales and earnings in Europe, Canada, the Middle East and Africa. Prior to 2006, Dr. Ashman held business leadership roles in the UK at AstraZeneca and Sanofi. Dr. Ashman holds a PhD in Biochemistry from the University of London: Royal Holloway and Bedford , UK, and a Bachelor's degree in Biochemistry from University College London, UK.
Research Interest
Oncology Business Biochemistry
